Which lung biopsy method is safer and more accurate?

NCT ID NCT07761351

First seen Aug 12, 2026 · Last updated Aug 13, 2026 · Updated 1 time

Summary

This trial compares two established biopsy methods for small lung nodules (≤2 cm): CT-guided percutaneous biopsy and shape-sensing robotic-assisted bronchoscopy with cone-beam CT. The goal is to see which approach is more effective at diagnosing cancer and which has fewer complications, such as pneumothorax (collapsed lung). Adults with a lung nodule needing biopsy may participate. The study will measure diagnostic accuracy and safety to help guide future clinical decisions.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Two biopsy procedures: shape-sensing robotic-assisted bronchoscopy with cone-beam CT (ssRAB with CBCT) and CT-guided percutaneous lung nodule biopsy
What this could lead to
If successful, this could help doctors choose the best biopsy method for small lung nodules, improving diagnostic accuracy and reducing complications like collapsed lungs.
What could go wrong
The trial is in phase 4 and involves 550 participants, but results may not apply to all patients or nodules. Both procedures carry risks, including bleeding or pneumothorax (collapsed lung).

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG CANCER (DIAGNOSIS) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

disease lung cancer lung neoplasm Multiple Pulmonary Nodules

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

More trials for these conditions

Other studies related to the condition(s) this trial covers.